The in vitro knockdown of LOX-1 in CRC cells impairs proliferation rate, hinders the maintenance of tumorigenicity and influences the presence of peculiar volatile organic compounds (VOCs) (189). This evidence concerns the gene OLR1 and colorectal carcinoma.